Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials : Annals of Surgery

Journal Logo

Original Articles

Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis

A Pooled Analysis of Eight Clinical Trials

Pannucci, Christopher J. MD, MS*; Fleming, Kory I. MPH; Varghese, Thomas K. Jr. MD, MS; Stringham, John MD; Huang, Lyen C. MD§; Pickron, T. Bartley MD§; Prazak, Ann Marie PharmD||; Bertolaccini, Corinne PharmD||; Momeni, Arash MD

Author Information
Annals of Surgery 276(6):p e682-e690, December 2022. | DOI: 10.1097/SLA.0000000000004589

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid